Orexigen Therapeutics, Inc. news

   Watch this stock
Showing stories 1 - 10 of about 76   

Articles published

OREX 4.39 +0.01 (0.23%)
price chart
BUZZ-Orexigen Therapeutics Inc: Diet drug launched
Contrave, which was approved last month, competes with Vivus Inc's Qsymia and Arena Pharmaceutical Inc's Belviq.
Not Even a Weight Loss Drug Could Stop Orexigen Therapeutics, Inc. From ...
Those fears have sparked a flurry of research and development into drugs that could help reduce the risk of type 2 diabetes by helping patients lose weight, including Orexigen Therapeutics' (NASDAQ: OREX ) recently approved Contrave. Yet despite ...
Related articles »  
Orexigen Launches Contrave - Watch For Traction
Orexigen (NASDAQ:OREX) announced today that the anti-obesity drug Contrave is now available for prescriptions in the United States.
Mid Day Movers: Orexigen Therapeutics, Inc. (NASDAQ:OREX), Alpha Natural ...  Market News Call
Perceive Facts on Declaration: Merck & Co. Inc. (NYSE:MRK), Steven ...  Street Newswire (registration)
Related articles »  
Stocks Buzz - Orexigen Therapeutics, Inc. (NASDAQ:OREX), SandRidge Energy ...
Houston, TX - 22 October, 2014 - (Techsonian) - Orexigen Therapeutics, Inc. (NASDAQ:OREX) and Takeda Pharmaceutical Company Limited (�Takeda�), together declared recently that Contrave� (naltrexone HCI and bupropion HCI) extended-release ...
Market Roundup: Orexigen Therapeutics (OREX), Cancer Genetics (CGIX ...  USMarketsDaily (blog)
Wall Street's Beloved Stocks: SanDisk Corporation (NASDAQ:SNDK ...  Markets Emerging
Related articles »  
Top Stock Watch: iGATE Corporation (NASDAQ:IGTE), Orexigen Therapeutics ...
iGATE Corporation (NASDAQ:IGTE) reported Q3 financial results on Wednesday, with earnings in-line with the consensus of analysts polled by Capital IQ and revenues slightly beating the consensus.
What To Watch For As Orexigen's Launch Approaches  Seeking Alpha (registration)
Active Movers - Knowles Corp (NYSE:KN), Orexigen Therapeutics, Inc ...  Techsonian (press release)
Related articles »  
Investor's Watch List � Orexigen Therapeutics, Inc. (NASDAQ:OREX), Gafisa ...
Birmingham, West Midlands - (TechSonian) - 24 Oct 2014 �Takeda Pharmaceuticals U.S.A., Inc. and Orexigen Therapeutics, Inc. (OREX) jointly released that Contrave� (naltrexone HCI and bupropion HCI) extended-release tablets are now available to ...
Health Care Stocks In Focus: Orexigen Therapeutics, Inc.(NASDAQ:OREX ...
Takeda Pharmaceutical Company, its entirely owned subsidiary Takeda Pharmaceuticals U.S.A and Orexigen Therapeutics, Inc. (NASDAQ:OREX) jointly declared that Contrave extensive launch tablets are now accessible to patients by instruction in drug ...
Related articles »  
Stocks to Watch - Orexigen Therapeutics, Inc. (NASDAQ:OREX), Lennox ...
Orexigen Therapeutics, Inc. (NASDAQ:OREX) and its its wholly-owned subsidiary Takeda Pharmaceuticals have launched sales of Contrave extended-release tablets for chronic weight management in adults.
Related articles »  
Orexigen On A Tear - In The Wrong Direction
Based on the review of the data and the company's response to the CHMP lists of questions, at the time of the withdrawal the CHMP had some concerns and was of the provisional opinion that Belviq could not have been approved for weight control in obese ...
Trending : Orexigen Therapeutics ,Achillion Pharma , Endo International ,Isis ...
Orexigen Therapeutics, Inc. (NASDAQ:OREX) : On September 23 and 24 , Meetings was held at New York and at Boston respectively hosted by Leerink.